Corl et al. provide a final piece of evidence for the specificity of the EGFR/ ERK pathway in regulating ethanol resistance. They found two subsets of cells in the fly brain that are responsible for the increase in ethanol sensitivity caused by overexpression of EGFR. Overexpression of EGFR in either dopaminergic neurons or insulin-producing cells (IPCs) in the fly brain is sufficient to increase ethanol resistance. The hppy gene is broadly expressed, so it will be critical to demonstrate that the site of action for hppy is also in dopaminergic neurons and IPCs. This would demonstrate the necessity of these two neuronal foci for ethanol resistance and would corroborate the observation that expression of a dominant-negative EGFR in IPCs is sufficient to increase ethanol sensitivity. Several regions of the fly brain have been implicated in ethanol resistance (Scholz, 2009 ). Therefore, it will be important to determine whether ethanol has broad targets in the brain with the ERK pathway mediating a subset of the behavioral responses to ethanol, or whether several redundant pathways are at work in ethanol resistance with the observed specificity due to the expression of an ERK pathway-interacting molecule that is unique to IPCs and dopaminergic neurons.
The new study by Corl et al. boosts our understanding of alcohol resistance. Yet, potential targets still abound. Signaling pathways using cAMP are contenders for targets of ethanol (Moore et al., 1998) . Ligand-gated ion channels, including the GABA, acetylcholine, glycine, and NMDA receptors, as well as various potassium channels have also been implicated as ethanol targets (Harris et al., 2008) . At least 100 different knockout mice exhibit alterations in ethanol sensitivity (Crabbe et al., 2006) . So far, however, remarkably few of these putative targets have been shown to bind directly to ethanol (Harris et al., 2008) . Thus, it will be important to test whether Happyhour itself or a regulator of Happyhour is a direct ethanol target. Hopefully, with further genetic screens and careful validation of targets we will eventually be able to distill a cohesive model for how ethanol alters behavior.
Systemic acquired resistance (SAR) is an inducible form of plant defense conferring broad-spectrum immunity to secondary infection of plant tissues above the initial infection site. SAR is triggered by systemic increases in salicylic acid (SA) levels following local infection by certain phytopathogens (Durrant and Dong, 2004) and results in the transcriptional activation of ~10% of the genes in the Arabidopsis genome. NPR1 (nonexpressor of pathogenesis-related genes 1) is a key SAR regulator. NPR1 contains a BTB/POZ (broad-complex, tramtrac, bric-à-brac/poxvirus, zinc finger) domain and an ankyrin-repeat domain. In the absence of infection, NPR1 is predominantly oligomeric and sequestered in the cytoplasm. Upon pathogen challenge, NPR1 is reduced to a monomeric state and translocates to the nucleus (Mou , 2003) . Within the nucleus, NPR1 physically interacts with TGA-bZIP transcription factors, inducing expression of defense response genes via a largely unknown mechanism to activate SAR. Spoel et al. (2009) now show that proteasome-mediated turnover of nuclear NPR1 regulates SAR. They find that blocking NPR1 degradation by use of proteasome inhibitors or by genetic knockdown of Cullin3 (CUL3; a component of cullin-RING ubiquitin ligases) activates expression of NPR1 target genes in otherwise uninduced cells, though to a lesser extent than salicylic acid treatment. Spoel et al. observe continual degradation of nuclear NPR1 in the absence of inducer, which they suggest is likely to restrict the ability of NPR1 to serve as a transcriptional coactivator. Thus, the authors reasoned that NPR1 degradation is vital to limiting transcriptional activation of SAR, thereby avoiding the fitness consequences associated with a constitutive defense response in the absence of infection. However, it is still unclear why NPR1 enters the nucleus in the absence of inducer or infection. One plausible explanation is that before NPR1 is targeted for degradation it may regulate additional genes in a manner independent of salicylic acid. NPR1 is recruited to a cis-regulatory element in the promoter of the PR1 (pathogenesisrelated 1) gene via an unknown protein(s), independent of the transcription factor TGA2 and salicylic acid. Yet, in this case, the PR1 gene is not activated (Figure 1 ; Rochon et al., 2006) .
A key observation made by Spoel and colleagues is that salicylic acid treatment or pathogen-dependent activation of SAR do not prevent NPR1 degradation. These unexpected results question whether nuclear NPR1 turnover is required for activation of target genes and disease resistance. The authors use a combination of genetic and biochemical approaches to block NPR1 turnover. They convincingly demonstrate that these transcriptional responses are compromised in (1) plants with diminished expression of the E3 ligases CUL3A and CUL3B, (2) plants that express an Depicted is a model for proteasome-mediated regulation of the transcriptional activity of NPR1. (A) In uninduced cells, a small amount of monomeric NPR1 (nonexpressor of pathogenesis-related genes 1) is constantly translocating from cytoplasm to the nucleus. NPR1 is recruited to the PR1 (pathogenesis-related gene 1) promoter through an unknown protein, but NPR1 and TGA transcription factors do not interact with each other and PR1 is not activated. Interaction of monomeric NPR1 with the CUL3-based E3 ligase protein complex is mediated by an unknown substrate adaptor protein (Adp-A) before recruitment of NPR1 to other target gene promoters. Ubiquitin (Ub)-dependent NPR1 degradation via a nuclear proteasome pathway prevents activation of NPR1 target genes. (B) In cells in which systemic acquired resistance is induced, a large amount of monomeric NPR1 translocates to the nucleus. A pool of NPR1 is phosphorylated before target gene expression. Both unphosphorylated and phosphorylated NPR1 may interact with TGA transcription factors. NPR1 is also likely to change partners from unknown protein to TGA transcription factors (Rochon et al., 2006) . PR1 is activated following the interaction of NPR1 with a TGA transcription factor. Unphosphorylated NPR1 is also recruited to target gene promoters by unknown transcription factors, leading to the assembly of the RNA polymerase II (Pol II) initiation complex and subsequent activation of target gene transcription. This pool of NPR1 may be phosphorylated by a kinase attached to Pol II. A high-affinity interaction of phosphorylated NPR1 and the CUL3-based E3 ligase protein complex is mediated by a different proposed substrate adaptor protein (Adp-B). Degradation of NPR1 following target gene activation allows fresh NPR1 to be recruited for the next round of transcription initiation. WRKY proteins regulate NPR1 transcript levels. Oligomerization of NPR1 occurs through intermolecular disulfide bonds. S-nitrosothiol (SNO)-facilitated NPR1 oligomerization and thioredoxin (TRX)-based monomerization are shown.
NPR1 protein with phosphorylation site mutations, and (3) wild-type plants treated with a proteasome inhibitor. They observe that the pattern of NPR1 degradation upon pathogen infection is biphasic. This led the authors to hypothesize that NPR1 is rapidly degraded after initial activation of target gene transcription in preparation for a new round of transcription initiation following recruitment of fresh NPR1 and other cofactors. Given that NPR1 degradation occurs constantly, it remains unclear how the cell maintains a proper homeostasis between NPR1 oligomers and monomers. Tada et al. (2008) recently showed that NPR1 is sequentially oxidized and reduced leading to NPR1 oligomerization and monomerization, respectively, following infection. Additionally, basal and salicylic acid-induced expression of NPR1 appears to be controlled by yet unidentified WRKY transcription factors (Figure 1 ; Eulgem and Somssich, 2007) . This suggests the existence of a feedback loop that maintains the oligomeric form of NPR1 at a particular concentration in the cytoplasm. This may explain not only the onset of efficient SAR by transcriptional regulation coupled with proteolysis but also the inactivation of SAR once cellular salicylic acid concentrations decrease to basal levels.
Cullin3-based E3 ligases target BTB domain-containing proteins for ubiquitindependent degradation, making NPR1 a potential target of this pathway. Spoel and coworkers demonstrate that NPR1 associates with CUL3 and other components of the COP9 signalosome, which controls proteasomal degradation. The authors further support their results with genetic data, showing that NPR1 protein stability is enhanced in plants deficient in COP9 or in plants deficient in both CUL3A and CUL3B. As NPR1 does not physically interact with CUL3, this interaction is likely to be mediated via an unidentified BTB domain-containing adaptor protein. Arabidopsis contains 77 BTB domain proteins, including five NPR1 paralogs (Stogios et al., 2005) . Zhang et al. (2006) have shown that NPR3 and NPR4, like NPR1, can interact with TGA transcription factors. Surprisingly, plants lacking both NPR3 and NPR4 display elevated disease resistance and PR1 gene expression, suggesting that these paralogs are negative regulators of defense gene transcription. These phenotypes are partially dependent on NPR1. Thus, it is possible that NPR1 paralogs may facilitate the NPR1-CUL3 interaction. It is also possible that NPR1 family members might interact with each other. To gain further understanding of CUL3 function in NPR1 degradation, the NPR1-CUL3 interaction should be investigated in plants lacking functional NPR3, NPR4, or TGA transcription factors. Moreover, the NPR1-CUL3 interaction should also be tested in plants expressing nonfunctional NPR1 alleles to confirm the specificity of this interaction.
Proteasome-mediated degradation is often regulated by posttranslational modifications including phosphorylation. Spoel and colleagues demonstrate that NPR1 turnover is promoted by phosphorylation of key residues (Ser11/ Ser15) present in an IkB-like phosphodegron motif. Distinct mechanisms lead to NPR1 degradation in uninduced and SAR-induced nuclei: NPR1 phosphorylation is not required for degradation in the former, whereas it is indispensable in the latter. It remains unclear how CUL3 differentiates between unphosphorylated and phosphorylated forms of NPR1 under different physiological conditions. Compared to wild-type NPR1, the NPR1 protein with phosphomimetic site mutations (NPR1 S11D/S15D ) exhibits increased degradation. In comparison, the NPR1 protein lacking these key phosphorylation sites (NPR1 S11A/S15A ) displays both reduced polyubiquitination and reduced interaction with CUL3. This led to the proposition that phosphorylation may create or stabilize a binding site for the CUL3-based ubiquitin ligase, thereby regulating degradation. However, other possible scenarios include additional modifications of NPR1 in response to an inducer of SAR or replacement of substrate adaptor protein(s) that may facilitate interaction between different forms of NPR1 and CUL3 (Figure 1 ).
In the model suggested by Spoel et al., promoter-targeted NPR1 is phosphorylated by a kinase associated with RNA polymerase II following transcription initiation. It is thereby marked as "exhausted," becomes rapidly ubiquitinated, and is then degraded. Notably, NPR1 S11D/S15D can still interact with TGA transcription factors and efficiently induces transcription. Therefore NPR1 phosphorylation could be independent of this turnover cycle. Alternatively, phosphorylation of a non-chromatin-bound pool of NPR1 could be mediated by a different kinase. A similar mechanism is shown for the yeast transcriptional activator Gcn4, in which two different kinases, an RNA polymerase II-associated Srb10 and a non-chromatin-bound Pho85, contribute to Gcn4 degradation either by targeting different pools of Gcn4 or by responding to different cellular signals (Chi et al., 2001) . Further phosphorylation-dependent modifications are also plausible, including ubiquitination of NPR1 to regulate its functional lifetime, as has been shown for human SRC-3 coactivator (Wu et al., 2007) . Spoel et al. (2009) provide deep insights into understanding the opposing roles of proteasome-mediated degradation in SAR. Future research will explore how salicylic acid and phosphorylation regulate the dynamic formation and disruption of NPR1-chromatin complexes.
